amylase 30250 UNT / lipase 8000 UNT / protease 28750 UNT Delayed Release Oral Capsule [Pertzye]
RxNorm concept 1294483, branded drug (sbd). Prescribable name: Pertzye 8000 UNT / 30,250 UNT / 28,750 UNT Delayed Release Oral Capsule.
- RxCUI
- 1294483
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1294483 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Pertzye (amylase 30,250 UNT / lipase 8,000 UNT / protease 28,750 UNT) Delayed Release Oral Capsule; Pertzye (amylases 30,250 UNT / endopeptidases 28,750 UNT / lipase 8000 UNT) Delayed Release Oral Capsule
Related concepts
- lipase 8000 UNT (SCDC, consists of)
- amylase 30250 UNT (SCDC, consists of)
- protease 28750 UNT (SCDC, consists of)
- amylase 30250 UNT / lipase 8000 UNT / protease 28750 UNT [Pertzye] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Pertzye (BN, has ingredient)
- amylase 30250 UNT / lipase 8000 UNT / protease 28750 UNT Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1294483 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1294483 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1294483. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.